Cesca Therapeutics ROA 2006-2018 | KOOL

Current and historical return on assets (ROA) values for Cesca Therapeutics (KOOL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Cesca Therapeutics ROA for the three months ending December 31, 2018 was -22.93%.
Cesca Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $-0.04B $0.02B -149.09%
2018-09-30 $-0.03B $0.02B -90.41%
2018-06-30 $-0.03B $0.02B -73.99%
2018-03-31 $-0.01B $0.05B -12.18%
2017-12-31 $-0.01B $0.05B -10.31%
2017-09-30 $-0.01B $0.05B -16.75%
2017-06-30 $-0.03B $0.05B -58.64%
2017-03-31 $-0.03B $0.05B -55.67%
2016-12-31 $-0.04B $0.05B -72.36%
2016-09-30 $-0.03B $0.05B -68.34%
2016-06-30 $-0.02B $0.05B -29.70%
2016-03-31 $-0.02B $0.05B -29.56%
2015-12-31 $-0.01B $0.05B -17.65%
2015-09-30 $-0.01B $0.05B -22.64%
2015-06-30 $-0.01B $0.05B -21.92%
2015-03-31 $-0.01B $0.05B -20.78%
2014-12-31 $-0.01B $0.06B -16.00%
2014-09-30 $-0.01B $0.06B -15.30%
2014-06-30 $-0.01B $0.06B -17.14%
2014-03-31 $-0.01B $0.05B -25.00%
2013-12-31 $-0.01B $0.01B -29.41%
2013-09-30 $-0.00B $0.02B -21.33%
2013-06-30 $-0.00B $0.02B -5.00%
2013-03-31 $-0.00B $0.02B -4.88%
2012-12-31 $-0.00B $0.02B -9.41%
2012-09-30 $-0.00B $0.02B -9.30%
2012-06-30 $-0.00B $0.02B -18.18%
2012-03-31 $-0.00B $0.02B -17.58%
2011-12-31 $-0.00B $0.02B -12.63%
2011-09-30 $-0.00B $0.02B -8.33%
2011-06-30 $-0.00B $0.02B -4.12%
2011-03-31 $-0.00B $0.03B -4.12%
2010-12-31 $-0.00B $0.02B -4.26%
2010-09-30 $-0.00B $0.02B -8.51%
2010-06-30 $-0.00B $0.02B -16.84%
2010-03-31 $-0.00B $0.02B -16.16%
2009-12-31 $-0.00B $0.02B -15.09%
2009-09-30 $-0.01B $0.03B -17.39%
2009-06-30 $-0.01B $0.03B -19.35%
2009-03-31 $-0.01B $0.03B -17.91%
2008-12-31 $-0.01B $0.03B -22.38%
2008-09-30 $-0.01B $0.03B -21.05%
2008-06-30 $-0.01B $0.04B -17.50%
2008-03-31 $-0.01B $0.04B -16.87%
2007-12-31 $-0.01B $0.04B -11.56%
2007-09-30 $-0.01B $0.04B -11.17%
2007-06-30 $-0.00B $0.04B -8.70%
2007-03-31 $-0.00B $0.05B -8.51%
2006-12-31 $-0.00B $0.05B -8.42%
2006-09-30 $-0.00B $0.05B -10.13%
2006-06-30 $-0.01B $0.05B -15.87%
2006-03-31 $-0.01B $0.05B -21.05%
2005-12-31 $-0.01B $0.02B -36.36%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.006B $0.010B
Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $107.551B 23.58
Intuitive Surgical (ISRG) United States $59.777B 55.08
Edwards Lifesciences (EW) United States $36.871B 36.92
Fresenius Medical Care AG KGaA (FMS) Germany $24.597B 16.84
IDEXX Laboratories (IDXX) United States $19.590B 53.32
Hologic (HOLX) United States $13.167B 19.91
Teleflex (TFX) United States $12.960B 28.39
Varian Medical Systems (VAR) United States $12.137B 31.02
ABIOMED (ABMD) United States $12.089B 79.80
STERIS (STE) United Kingdom $10.826B 27.82
DexCom (DXCM) United States $10.753B 407.31
Masimo (MASI) United States $6.857B 42.57
Penumbra (PEN) United States $4.739B 268.16
Globus Medical (GMED) United States $4.493B 27.27
Integra LifeSciences Holdings (IART) United States $4.384B 20.64
Wright Medical Group (WMGI) Netherlands $3.631B 0.00
Tandem Diabetes Care (TNDM) United States $3.489B 0.00
LivaNova (LIVN) United Kingdom $3.353B 20.67
Cantel Medical (CMD) United States $2.763B 27.48
Glaukos (GKOS) United States $2.598B 0.00
Integer Holdings (ITGR) United States $2.229B 18.12
AVANOS MEDICAL, INC (AVNS) United States $1.964B 21.33
Nevro (NVRO) United States $1.902B 0.00
Inogen (INGN) United States $1.819B 36.06
OPKO Health (OPK) United States $1.454B 0.00
SILK RD MEDICAL (SILK) United States $1.143B 0.00
Pacific Biosciences Of California (PACB) United States $1.111B 0.00
CryoLife (CRY) United States $1.086B 117.08
Accelerate Diagnostics (AXDX) United States $1.060B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $1.041B 28.31
Shockwave Medical (SWAV) United States $1.037B 0.00
Luminex (LMNX) United States $1.014B 45.98
Veracyte (VCYT) United States $0.954B 0.00
Fluidigm (FLDM) United States $0.945B 0.00
Intersect ENT (XENT) United States $0.936B 0.00
Tactile Systems Technology (TCMD) United States $0.913B 173.29
Mesa Laboratories (MLAB) United States $0.894B 36.55
Natus Medical (BABY) United States $0.855B 19.83
AxoGen (AXGN) United States $0.833B 0.00
AngioDynamics (ANGO) United States $0.758B 26.44
ViewRay (VRAY) United States $0.695B 0.00
OrthoPediatrics (KIDS) United States $0.565B 0.00
Quotient (QTNT) Switzerland $0.538B 0.00
TransEnterix (TRXC) United States $0.425B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.425B 44.31
Corindus Vascular Robotics (CVRS) United States $0.417B 0.00
GenMark Diagnostics (GNMK) United States $0.409B 0.00
Si-Bone (SIBN) United States $0.399B 0.00
RTI Surgical (RTIX) United States $0.374B 46.18
Accuray (ARAY) United States $0.373B 0.00
Pulse Biosciences (PLSE) United States $0.340B 0.00
IRadimed (IRMD) United States $0.318B 67.23
Neuronetics (STIM) United States $0.282B 0.00
SeaSpine Holdings (SPNE) United States $0.268B 0.00
Sientra (SIEN) United States $0.238B 0.00
CRH Medical (CRHM) Canada $0.207B 48.00
SOLITON INC (SOLY) $0.172B 0.00
ConforMIS (CFMS) United States $0.166B 0.00
Nuvectra (NVTR) United States $0.166B 0.00
Ekso Bionics Holdings (EKSO) United States $0.148B 0.00
EDAP TMS (EDAP) France $0.143B 492.00
Alphatec Holdings (ATEC) United States $0.140B 0.00
Biosig Technologies (BSGM) United States $0.134B 0.00
T2 Biosystems (TTOO) United States $0.116B 0.00
Second Sight Medical Products (EYES) United States $0.111B 0.00
Sensus Healthcare (SRTS) United States $0.105B 0.00
Vermillion (VRML) United States $0.097B 0.00
Apollo Endosurgery (APEN) United States $0.075B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.074B 0.00
Ra Medical Systems (RMED) United States $0.070B 0.00
Titan Medical (TMDI) Canada $0.059B 0.00
Helius Medical Technologies (HSDT) United States $0.054B 0.00
Electromed (ELMD) United States $0.048B 25.00
Xtant Medical Holdings (XTNT) United States $0.039B 0.00
PAVmed (PAVM) United States $0.036B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
Neovasc (NVCN) Canada $0.031B 0.00
Avinger (AVGR) United States $0.031B 0.00
Atossa Genetics (ATOS) United States $0.029B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.029B 0.00
DarioHealth (DRIO) Israel $0.027B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
Restoration Robotics (HAIR) United States $0.023B 0.00
Viveve Medical (VIVE) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.020B 65.67
American Shared Hospital Services (AMS) United States $0.016B 15.44
Dynatronics (DYNT) United States $0.016B 0.00
Nanovibronix (NAOV) United States $0.014B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
ReWalk Robotics (RWLK) Israel $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
ALCON INC (ALC) $0.000B 0.00